Demonstrates improved antioxidant activity and controlled release of essential oil in microcapsules, suggesting effective protection methods.
This study aimed to enhance the stability and achieve controlled release of Pistacia lentiscus essential oil (PLEOs) via microencapsulation using a sodium alginate–gelatine complex coacervation system. Chemical composition of PLEOs was analysed by gas chromatography-mass spectrometry. Microcapsules were characterised using Fourier-transform infra-red spectroscopy, X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, and scanning electron microscopy. Optimised PLEOs microcapsules exhibited a zeta potential of −28.33 ± 0.90 mV, encapsulation efficiency (93.28 ± 0.31% w/w), retention efficiency (95.30 ± 0.11% w/w), and particle diameters from 10 to 40 µm. Thermal stability was significantly improved, with the degradation stage shifting from 110–340 ± 5 °C for PLEOs to 200–370 ± 5 °C after encapsulation. Antioxidant activity of PLEOs microcapsules increased to 56.0 ± 3.1%. In vitro digestion showed pH-dependent sustained release (15–60% w/w over 200 min; R2 ≥ 0.95). These findings demonstrate that complex coacervation effectively protects PLEOs and ensures controlled release.
No takes yet. Share an insight, caveat, or question.
Dehane et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: